Psychological impact of endometrial monitoring in tamoxifen-treated postmenopausal breast cancer patients

被引:1
|
作者
Demyttenaere, K
Gheldof, M
Enzlin, P
Timmerman, D
Deprest, J
Bourne, T
Vergote, I
机构
[1] Catholic Univ Louvain, Dept Psychiat, Hosp Gasthuisberg, B-3000 Louvain, Belgium
[2] Catholic Univ Louvain, Dept Obstet & Gynecol, Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] St George Hosp, Sch Med, Acad Dept Obstet & Gynaecol, London, England
来源
关键词
breast cancer; endometrial surveillance; psychological impact; compliance;
D O I
10.3109/01674820009085592
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
In view of the higher incidence of endometrial pathology In tamoxifen-treated; breast cancer patients, it has been recommended that endometrial surveillance be performed on these women by means of transvaginal sonography. Our study investigated how breast cancer patients experience the endometrial surveillance and which personality factors influence this experience.: We also: studied compliance with the recommended examination. Fifty-three consecutive asymptomatic postmenopausal breast cancer patients who had taken tamoxifen for at least 6 months were included. Our results show that 23 % of the women felt very anxious just before the examination. One woman in five evaluated the procedure as annoying, unpleasant, invasive and awkward, but only 3 % found it really unacceptable. Difficulties in coping with mastectomy as well as anxiety negatively affected the experience of the examination. One in six women were doubtful about their ability to comply with such an examination in the future Women who have difficulties in coming to terms with the mastectomy, anxious, women, and women with a low tolerance, towards common medical procedures are at especial risk of becoming dropouts. Suggestions are made for developing strategies that might improve these women's compliance.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 50 条
  • [21] Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer
    Shushan, A
    Peretz, T
    Uziely, B
    Lewin, A
    MorYosef, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 141 - 144
  • [22] DNA-CONTENT IN ENDOMETRIAL CARCINOMA OF TAMOXIFEN-TREATED BREAST-CANCER PATIENTS
    MOBERGER, B
    FORNANDER, T
    HELLSTROM, AC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (02) : 131 - 134
  • [24] CHANGES MIMICKING ENDOMETRIAL NEOPLASIA IN POSTMENOPAUSAL, TAMOXIFEN-TREATED WOMEN WITH BREAST-CANCER - A TRANSVAGINAL DOPPLER STUDY
    ACHIRON, R
    LIPITZ, S
    SIVAN, E
    GOLDENBERG, M
    HOROVITZ, A
    FRENKEL, Y
    MASHIACH, S
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1995, 6 (02) : 116 - 120
  • [25] Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors
    Sestak, Ivana
    Cuzick, Jack
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 425 - 432
  • [26] Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients
    Giorda, G
    Crivellari, D
    Veronesi, A
    Perin, T
    Campagnutta, E
    Carbone, A
    Scarabelli, C
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (10) : 975 - 980
  • [27] Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women
    Cohen, I
    Azaria, R
    Shapira, J
    Yigael, D
    Tepper, R
    CANCER, 2002, 94 (12) : 3101 - 3106
  • [28] Assessment of Endometrial Hyperplasias in 69 Tamoxifen-Treated Asymptomatic Postmenopausal Women
    Iyibozkurt, Ahmet Cem
    Akhan, Suleyman Engin
    Topuz, Samet
    Salihoglu, Yavuz
    Bengisu, Ergin
    Berkman, Sinan
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 4 (03) : 199 - 204
  • [29] Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women
    Timmerman, D
    Neven, P
    Deprest, J
    Konstantinovic, ML
    Vergote, I
    CANCER, 2003, 98 (02) : 431 - 432
  • [30] Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients
    Tepper, R
    Beyth, Y
    Altareas, MM
    Zalel, Y
    Shapira, J
    Cordoba, M
    Cohen, I
    GYNECOLOGIC ONCOLOGY, 1997, 64 (03) : 386 - 391